Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127198921 | 12719892 | 1 | I | 20160705 | 20160712 | 20160907 | 20160907 | EXP | GB-AMGEN-GBRSP2016091513 | AMGEN | 70.00 | YR | E | F | Y | 69.00000 | KG | 20160907 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127198921 | 12719892 | 1 | PS | NPLATE | ROMIPLOSTIM | 1 | Subcutaneous | 75-150 MUG, QWK | 75 | UG | Y | 125268 | 75 | UG | POWDER FOR INJECTION | /wk | |||
| 127198921 | 12719892 | 2 | C | TOCILIZUMAB | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 127198921 | 12719892 | 3 | C | CALCICHEW-D3 FORTE | CALCIUMCHOLECALCIFEROL | 1 | UNK UNK, BID | 0 | BID | ||||||||||
| 127198921 | 12719892 | 4 | C | DICLOFENAC SODIUM. | DICLOFENAC SODIUM | 1 | 75 MG, BID | 0 | 75 | MG | BID | ||||||||
| 127198921 | 12719892 | 5 | C | COSOPT | DORZOLAMIDE HYDROCHLORIDETIMOLOL MALEATE | 1 | 2 % + 0.5 %, BID | 0 | BID | ||||||||||
| 127198921 | 12719892 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 127198921 | 12719892 | 7 | C | GLUCOSAMINE + CHONDROITIN | 2 | Oral | 500 MG, QD | 0 | 500 | MG | QD | ||||||||
| 127198921 | 12719892 | 8 | C | LATANOPROST. | LATANOPROST | 1 | 0.005 %, QD | 0 | .005 | PCT | QD | ||||||||
| 127198921 | 12719892 | 9 | C | LORMETAZEPAM | LORMETAZEPAM | 1 | 0.5 MG, QD | 0 | .5 | MG | QD | ||||||||
| 127198921 | 12719892 | 10 | C | ZOMORPH | MORPHINE SULFATE | 1 | 10 MG, BID | 0 | 10 | MG | BID | ||||||||
| 127198921 | 12719892 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 127198921 | 12719892 | 12 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 500 MG, 4 TIMES A DAY, UNK | 0 | 500 | MG | |||||||||
| 127198921 | 12719892 | 13 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 17.5 MG, QD | 0 | 17.5 | MG | QD | ||||||||
| 127198921 | 12719892 | 14 | C | TRAMADOL. | TRAMADOL | 1 | 50 MG, FOUR TIMES A DAY UNK | 0 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127198921 | 12719892 | 1 | Immune thrombocytopenic purpura |
| 127198921 | 12719892 | 2 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127198921 | 12719892 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127198921 | 12719892 | Platelet count increased | |
| 127198921 | 12719892 | Thrombocytosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127198921 | 12719892 | 1 | 201410 | 20160705 | 0 |